Decision-analytic modeling of concomittant left atrial appendage closure versus lifelong anticoagulation after atrial fibrillation ablation: cost-effectiveness and lifetime outcomes

12 April 2026 (08:00 - 18:30)

Organised by:

Abstract

Sign in to view the resources

About the speaker

Doctor Marton Boga

Gottsegen National Cardiovascular Center, Budapest (Hungary)

196 More presentations in this session

Presentation thumbnail

Electrocardiographic differentiation of narrow QRS complex tachycardia: validation of the new aVL and aVR criteria and a unifying approach to ECG analysis

Doctor J. Stec (Cracow, PL)

Abstract Slides Video

Presentation thumbnail

Characterization of paroxysmal atrial fibrillation in atrial septal defects: contribution of a left atrial substrate

Doctor N. Ramdat Misier (Rotterdam, NL)

Abstract Slides

Presentation thumbnail

Spatial distribution of effective refractory period in atrial fibrillation patients

Associate Professor A. Loewe (Karlsruhe, DE)

Abstract Slides

Presentation thumbnail

Early onset atrial fibrillation as a marker of inherited cardiomyopathy: lessons from combined imaging and genetic assessment

Doctor V. Rella (Milan, IT)

Abstract Slides Video

Presentation thumbnail

BMI discrepancy and new-onset atrial fibrillation: findings from UK biobank

Doctor J. Choi (Seoul, KR)

Abstract Slides Video

Access the full session

Session thumbnail

Poster session (1): supraventricular arrhythmias

The Event

Event poster

EHRA 2026

12 April 2026 08:00 CET

You may be interested in

Congress Presentation

Left atrial appendage closure in atrial fibrillation: gaps in knowledge

Congress Session

Stroke prevention in atrial fibrillation: do not forget the left atrial appendage!

Congress Session

LAAC and AF ablation are evolving, are you?

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources